Tackling health equity requires sustained, comprehensive, and collaborative interventions
Amgen Inc., an Advocate level sponsor of the 2023 BIO Patient & Health Advocacy Summit, provided their approval to share this previously published article …
Amgen Inc., an Advocate level sponsor of the 2023 BIO Patient & Health Advocacy Summit, provided their approval to share this previously published article …
The U.S. Food and Drug Administration (FDA) has approved TIBSOVO (ivosidenib) as a treatment for a rare blood cancer, the agency said in an …
Dr. Mary-Ann Etiebet, Associate Vice President, Health Equity, Merck, has more than two decades of experience working across the public and private sectors to …
Turning insights into action: building a U.S. health system that delivers for all women Read More »
Blood clots are commonly missed. According to the National Blood Clot Alliance (NBCA), “fewer than 1 in 4 people have any recognition of blood …
A new class of medicines provides hope for patients at risk of dangerous blood clots Read More »
Patients’ stories are powerful—especially when it comes to advocacy, agreed panelists at the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit. An October …
Patients are your best advocates – here’s how to support them Read More »
Sepsis is the third most common cause of disease-related death in the United States. Bacterial infections are the most common cause of sepsis. But …
How COVID-19 is increasing incidence of another life-threatening condition Read More »
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during …
“Patient advocacy is at heart of what BIO is working to accomplish within this community to extend the lives of patients,” said Rachel King, …
Why patient advocacy is ‘at the heart’ of the biotech sector’s work Read More »
“The Inflation Reduction Act (IRA) was one of President Biden’s signature achievements and will help many Americans,” began Christina Hochul of Alexion Pharmaceuticals, Inc., …
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs Read More »
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit is kicking off in Washington, D.C. Now in its 12th year, the event brings …
What we’re watching at the 2023 Patient & Health Advocacy Summit Read More »